beCLomethasone Efficacy in Acute Rhinosinusitis - CLEAR Study

Conditions

• Acute Rhinosinusitis

Interventions

• DRUG: beclomethasone dipropionate 800 mcg/2 ml suspension for nebulization,one administration b.i.d. for 14 days
• DRUG: placebo 2 ml suspension for nebulization, one administration b.i.d. for 14 days

Sponsor

Chiesi Farmaceutici S.p.A.